Screening Protocol for Subjects Being Evaluated for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols

计划入组 587 人 · 首次发布于 2009 年 8 月 28 日

Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies

计划入组 88 人 · 首次发布于 2009 年 10 月 15 日

Collection of Blood, Bone Marrow, Leukapheresis, and Tissue Biopsy Samples From Patients and Their Family Members for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases Laboratory Research Studies

计划入组 96 人 · 首次发布于 2010 年 9 月 14 日

therapeutics (inflammatory diseases )

anti-inflammatory agents (inflammatory diseases)

anti-inflammatory agent (inflammatory diseases)

Center For Molecular Medicine and Immunology, Inc.

United States

La Jolla Institute For Immunology

United States

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

United States

Agomab Therapeutics Raises $200 Million in IPO to Advance Fibrotic Disease Therapies

Inimmune Appoints New Chief Medical Officer and Head of Financial Strategy Ahead of Phase 2 Allergic Rhinitis Data

Acelyrin Shifts Focus to Thyroid Eye Disease Drug, Halts Further Investment in Izokibep